JCO SJR and Scopus Metrics: What the Numbers Actually Tell Authors
JCO's Scopus profile confirms what oncologists already know: this is a top clinical oncology journal. The useful question is whether your paper actually behaves like a JCO paper.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Quick answer: Journal of Clinical Oncology remains one of the strongest clinical oncology journals under Scopus-style metrics. Current Scopus-linked browser data reports a 2024 SJR of 11.205, a CiteScore of 38.9, and a rank of 9 out of 415 in Oncology. That confirms elite status, but the submission decision still depends on whether the manuscript is truly practice-shaping enough for JCO rather than just a strong oncology study.
The core metric picture
Metric | 2024 value | What it tells you |
|---|---|---|
SJR | 11.205 | Prestige-weighted influence is elite |
CiteScore | 38.9 | Four-year citation performance is very strong |
SNIP | 5.983 | Field-normalized impact is also high |
Rank | 9 / 415 in Oncology | The journal sits near the top of clinical oncology |
Quartile | Q1 | The journal remains firmly top-tier |
JCR context | Impact factor 41.9 | Web of Science tells the same elite clinical story |
The useful reading is that JCO is not just a strong ASCO journal. It remains central in the clinical-oncology citation network.
What the metrics actually help with
They help clarify where JCO sits:
- in the very top layer of clinical oncology journals
- strongest for studies with direct implications for treatment, management, or standards of care
- different from biology-first oncology flagships like Cancer Cell
That is useful when the shortlist includes JCO, Lancet Oncology, JAMA Oncology, or a narrower disease-specific venue.
What the metrics do not answer
They do not tell you:
- whether the study really changes practice
- whether the endpoint story is strong enough
- whether the manuscript is too narrow in audience
- whether another top oncology journal is a better tonal fit
Those are still the real submission questions.
Why the profile matters for authors
At this SJR level, JCO can be strict about clinical consequence. The journal's profile reflects a specific editorial product:
- trials or studies oncologists will actually use
- strong clinical interpretation
- evidence that matters beyond one disease micro-community
- papers that continue to shape guidelines, reviews, and treatment discussions
That is why the numbers are useful. They show JCO's authority is real enough that it does not need to stretch for merely respectable oncology papers.
What should drive the submission decision instead
The better question is whether the manuscript is truly a JCO paper.
That is why the better next reads are:
- Is JCO a good journal?
- JCO submission guide
- JCO submission process
- JCO impact factor
If the study is important but not really practice-shaping, the metrics do not rescue the mismatch. They only explain why JCO can reject many good oncology manuscripts.
Practical verdict
JCO has a genuine flagship Scopus profile for clinical oncology. That makes it a powerful target when the manuscript is clinically consequential, methodologically rigorous, and broad enough to matter across oncology practice.
But the author takeaway should still be about fit, not aspiration. If the paper would not change how oncologists think or act, the metric is already warning you. A free Manusights scan is the fastest way to pressure-test that before submission.
- JCO submission guide, Manusights.
Sources
- 1. Journal of Clinical Oncology journal browser entry, University of Amsterdam journal browser.
- 2. JCO journal page, ASCO Publications.
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Want the full journal picture?
Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.
These pages attract evaluation intent more than upload-ready intent.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Conversion step
Want the full journal picture?
These pages attract evaluation intent more than upload-ready intent.